6-ADAC,
ADAC agonist,
adenosine amine congener,
N(6)-((aminoethylamino)carbonyl)methylphenyladenosine,
N(6)-(4-((((2-aminoethyl)amino)carbonyl)methyl)phenyl)adenosine,
CHEMBL1512545,
96760-69-9,
BDBM50396917,
ADAC,
6-Adac,
MLS002153192,
CHEMBL603401,
SCHEMBL3486807,
Adenosine amine congener hydrate,
DTXSID60914331,
HMS2231C21,
ZINC4475057,
BDBM50367265,
N-(4-(2-((4-(2-((2-Aminoethyl)amino)-2-oxoethyl)phenyl)amino)-2-oxoethyl)phenyl)adenosine,
NCGC00163296-01,
SMR001230680,
A825579,
Adenosine, N-(4-(2-((4-(2-((2-aminoethyl)amino)-2-oxoethyl)phenyl)amino)-2-oxoethyl)phenyl)-,
N-(2-aminoethyl)-2-[4-[[2-[4-[[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]-6-purinyl]amino]phenyl]-1-oxoethyl]amino]phenyl]acetamide,
N-(2-azanylethyl)-2-[4-[2-[4-[[9-[(2R,3R,4S,5R)-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]purin-6-yl]amino]phenyl]ethanoylamino]phenyl]ethanamide,
N-[4-[[[[4-[[[(2-Aminoethyl)amino]carbonyl]methyl]phenyl]amino]carbonyl]methyl]phenyl]adenosine,
N-{4-[(2-Amino-ethylcarbamoyl)-methyl]-phenyl}-2-{4-[9-((2R,3R,4S,5R)-3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-ylamino]-phenyl}-acetamide,
N-{4-[2-(4-{2-[(2-Aminoethyl)imino]-2-hydroxyethyl}anilino)-2-oxoethyl]phenyl}-9-pentofuranosyl-9H-purin-6-amine,
N6-[4-[[[4-[[[(2-Aminoethyl)amino]carbonyl]methyl]-anilino]carbonyl]methyl]phenyl]adenosine,
Adenosine amine congener,
AC1L2POH,
AC1Q5PIM,
C28H32N8O6,
AR-1J8846,
CID126054,
C28-H32-N8-O6,
N(6)-((Aminoethylamino)carbonyl)methylphenyladenosine,
n-(4-{2-[(4-{2-[(2-aminoethyl)amino]-2-oxoethyl}phenyl)amino]-2-oxoethyl}phenyl)adenosine,
4152-09-4,
N-(2-aminoethyl)-2-[4-[[2-[4-[[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]amino]phenyl]acetyl]amino]phenyl]acetamide,